Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: An immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleuraMIETTINEN, Markku; SARLOMO-RIKALA, Maarit.The American journal of surgical pathology. 2003, Vol 27, Num 2, pp 150-158, issn 0147-5185, 9 p.Article

Claudin-5 as an Immunohistochemical Marker for Angiosarcoma and HemangioendotheliomasMIETTINEN, Markku; SARLOMO-RIKALA, Maarit; WANG, Zeng-Feng et al.The American journal of surgical pathology. 2011, Vol 35, Num 12, pp 1848-1856, issn 0147-5185, 9 p.Article

Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomasSARLOMO-RIKALA, Maarit; TSUJIMURA, Tohru; LENDAHL, Urban et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2002, Vol 110, Num 6, pp 499-507, issn 0903-4641Article

Gastrointestinal stromal tumors and leiomyosarcomas in the colon : A clinicopathologic, immunohistochemical, and molecular genetic study of 44 casesMIETTINEN, Markku; SARLOMO-RIKALA, Maarit; SOBIN, Leslie H et al.The American journal of surgical pathology. 2000, Vol 24, Num 10, pp 1339-1352, issn 0147-5185Article

Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinomaKUJAWSKI, Maciej; RYDZANICZ, Malgorzata; SARLOMO-RIKALA, Maarit et al.Cancer genetics and cytogenetics. 2002, Vol 137, Num 1, pp 54-58, issn 0165-4608Article

Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus : A clinicopathologic, immunohistochemical, and molecular genetic study of 144 casesMIETTINEN, Markku; FURLONG, Mary; SARLOMO-RIKALA, Maarit et al.The American journal of surgical pathology. 2001, Vol 25, Num 9, pp 1121-1133, issn 0147-5185Article

Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma : Comparison with four other melanoma markersMIETTINEN, Markku; FERNANDEZ, Martin; FRANSSILA, Kaarle et al.The American journal of surgical pathology. 2001, Vol 25, Num 2, pp 205-211, issn 0147-5185Article

Chromosomal aberrations in malignant gastrointestinal stromal tumors: Correlation with c-KIT gene mutationDEBIEC-RYCHTER, Maria; LASOTA, Jerzy; SARLOMO-RIKALA, Maarit et al.Cancer genetics and cytogenetics. 2001, Vol 128, Num 1, pp 24-30, issn 0165-4608Conference Paper

Succinate Dehydrogenase-Deficient GISTs: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 66 Gastric GISTs With Predilection to Young AgeMIETTINEN, Markku; WANG, Zeng-Feng; SARLOMO-RIKALA, Maarit et al.The American journal of surgical pathology. 2011, Vol 35, Num 11, pp 1712-1721, issn 0147-5185, 10 p.Article

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: A study of 200 casesLASOTA, Jerzy; WOZNIAK, Agnieszka; SARLOMO-RIKALA, Maarit et al.The American journal of pathology. 2000, Vol 157, Num 4, pp 1091-1095, issn 0002-9440Article

Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 casesMIETTINEN, Markku; KOPCZYNSKI, Janusz; MAKHLOUF, Hala R et al.The American journal of surgical pathology. 2003, Vol 27, Num 5, pp 625-641, issn 0147-5185, 17 p.Article

Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumorsPYLKKÄNEN, Lea; SARLOMO-RIKALA, Maarit; WESSMAN, Maija et al.Human pathology. 2003, Vol 34, Num 9, pp 872-879, issn 0046-8177, 8 p.Article

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumoursSIHTO, Harri; FRANSSILA, Kaarle; TANNER, Minna et al.Scandinavian journal of gastroenterology. 2006, Vol 41, Num 7, pp 805-811, issn 0036-5521, 7 p.Article

Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of ScreeningSIHTO, Harri; LUNDIN, Johan; ISOLA, Jorma et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4103-4110, issn 1078-0432, 8 p.Article

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumorJOENSUU, Heikki; ROBERTS, Peter J; DEMETRI, George D et al.The New England journal of medicine. 2001, Vol 344, Num 14, pp 1052-1056, issn 0028-4793Article

KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal originLASOTA, Jerzy; KOPCZYNSKI, Janusz; MIETTINEN, Markku et al.Human pathology. 2003, Vol 34, Num 12, pp 1306-1312, issn 0046-8177, 7 p.Article

Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant ImatinibJOENSUU, Heikki; ERIKSSON, Mikael; SCHLEMMER, Marcus et al.Cancer. 2014, Vol 120, Num 15, pp 2325-2333, issn 0008-543X, 9 p.Article

One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized TrialJOENSUU, Heikki; ERIKSSON, Mikael; SCHLEMMER, Marcus et al.JAMA, the journal of the American Medical Association. 2012, Vol 307, Num 12, pp 1265-1272, issn 0098-7484, 8 p.Article

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumorsLASOTA, Jerzy; JERZAK VEL DOBOSZ, Anna; SCHNEIDER-STOCK, Regine et al.Laboratory investigation. 2007, Vol 87, Num 10, pp 1029-1041, issn 0023-6837, 13 p.Article